Shenzhen ScienCare Pharmaceutical Co.,Ltd.

Shenzhen ScienCare Pharmaceutical Co.,Ltd. is committed to the independent research and development, production and sales of innovative drugs, with the goal of becoming the world's first-class scientific and innovative medical industry enterprises

ScienCare Pharmaceutical focuses on the research and development of innovative drugs with independent intellectual property rights, and is invested by several funds such as Shenzhen Capital fortune, Shenzhen Capital Group co.,ltd. , People's Daily Online, Xiaoxiang Capital ，etc., with strong international competitiveness and industry-leading advantages.

ScienCare Pharmaceutical is headquartered in Pingshan District, Shenzhen, with a total area of 8,000 square meters. Since its establishment in 2017, ScienCare Pharmaceutical has been based in China and facing the world, focusing on scientific research and technological innovation.

ScienCare Pharmaceutical lucubrate drug treatment field for many years, it‘s predecessor has more than 10 years of sustained release technology research and development base, to master the international advanced slow controlled release of core technology, has rich experience in pharmaceutical research and clinical research, research and development pipeline to focus on drug addiction and mental illness, the main species throughout the nervous spirit and many diseases such as tumor, diabetes.

In the future, ScienCare Pharmaceutical will build a first-class research and development center for controlled and controlled release drugs, build an innovative research and development platform for drug delivery system in the world, industrialize the products developed, and build a comprehensive group of "medicine, drug and research" integrating drug research and development, clinical research, drug production and sales.